Search Results - Stawujak, G

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Insulin glargine is cost-effective in treatment of patients with diabetes type-2 in whom nph insulin does not provide adequate glycaemic control – The case of poland

    Insulin glargine is cost-effective in treatment of patients with diabetes type-2 in whom nph insulin does not provide adequate glycaemic control – The case of poland by Szmurlo, D, Kostrzewska, K, Fundament, T, Kopec, G, Wojtarowicz, M, Drzal, R, Stawujak, G, Labak-Klimasara, M, Glasek, M, Lis, J, Plisko, R

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    PDB52 - Insulin glargine is cost-effective in treatment of patients with diabetes type-2 in whom nph insulin does not provide adequate glycaemic control – The case of poland

    PDB52 - Insulin glargine is cost-effective in treatment of patients with diabetes type-2 in whom nph insulin does not provide adequate glycaemic control – The case of poland by Szmurlo, D., Kostrzewska, K., Fundament, T., Kopec, G., Wojtarowicz, M., Drzal, R., Stawujak, G., Labak-Klimasara, M., Glasek, M., Lis, J., Plisko, R.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: